Sionna Therapeutics, Inc Common Stock

Sionna Therapeutics, Inc Common Stock

Quarterly Financials

Values in thousands2026-09-302026-06-302026-03-312025-12-31
Revenue
$0
$0
$0
$0
Gross Profit
-154
-154
-152
EBITDA
-28,465
-29,731
-26,625
-16,760
EBIT
-28,619
-29,886
-26,779
-17,263
Net Income
-32,418
-29,886
-26,779
-20,440
Net Change In Cash
0
0
0
0
Free Cash Flow
-18,723
-44,060
-21,840
-16,830
Cash
83,878
63,322
63,324
58,451
Basic Shares
45,208
45,148
44,921
39,962

Annual Financials

Values in thousands2025-12-312024-12-312023-12-312022-12-31
Revenue
$0
$0
$0
$0
Gross Profit
-647
-668
EBITDA
-74,621
-61,020
-46,680
-40,118
EBIT
-75,268
-61,688
-47,263
-40,240
Net Income
-75,268
-61,688
-47,263
-40,240
Net Change In Cash
0
0
0
0
Free Cash Flow
-66,674
-52,814
-44,815
-37,942
Cash
58,451
37,788
38,521
54,837
Basic Shares
39,962
44,124
44,124
44,124

Earnings Calls

QuarterEPS
2026-09-30
-$0.72
2026-06-30
-$0.66
2026-03-31
-$0.60
2025-12-31
-$0.46